Clinical Trials for Halia Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Halia Therapeutics

Clinical Trials (2)

NCT07172867
A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
PHASE2Not yet recruiting
50 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor0 locations
NCT07052006
HT-6184 in Subjects With MDS
PHASE2Active, not recruiting
37 participants
Started: Dec 9, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor10 locations